US 9068185
Antisense modulation of nuclear hormone receptors
granted A61PA61P1/00A61P11/06
Quick answer
US patent 9068185 (Antisense modulation of nuclear hormone receptors) held by Sarepta Therapeutics, Inc. expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/00, A61P11/06, A61P19/02, A61P25/28